• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Delayed antibiotic prescribing for respiratory infections may decrease unnecessary antibiotic use

byShayna BejaimalandJames Jiang
December 23, 2015
in Infectious Disease, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this randomized controlled trial, delayed antibiotic prescribing strategies resulted in decreased antibiotic use.

2. Patients in the delayed prescription or no antibiotic groups reported longer duration of moderate to severe symptoms as compared to the immediate antibiotic group. However, no placebo group existed for complete comparison.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Many upper respiratory illnesses in ambulatory patients are due to viruses, and therefore antibiotics have limited use. In primary care, where there may be higher diagnostic uncertainty, delayed antibiotic prescribing strategies have been suggested to reduce unnecessary antibiotic use. This open-label randomized controlled trial aimed to determine the efficacy and safety of two delayed antibiotic strategies in acute uncomplicated respiratory infections as compared to immediate antibiotic prescription or no offer of antibiotics.

The two delayed antibiotic prescribing strategies resulted in decreased antibiotic use. Patients in the delayed antibiotic and no antibiotic groups, however, had a longer duration of symptoms self-reported as moderate-to-severe than those with immediate prescriptions. Overall, patient satisfaction was high and similar across all groups. While this is a randomized controlled trial, a major limitation to this study is the lack of a placebo group. There may be a component of bias as well, given all data is based on self-reported daily questionnaires.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

Risk of bloodstream infections with indwelling peripheral catheters increase after 3 days

#VisualAbstract Seven Days of Antibiotic Treatment Non-inferior to 14 Days for Bloodstream Infections

The 2 Minute Medicine Podcast Episode 54

Relevant Reading: Delayed antibiotics for respiratory infections

In-Depth [randomized controlled trial]: This open-label, randomized controlled trial was conducted between December 2009 and July 2012 in 23 primary care centers in Spain. Eligible patients were adults with acute uncomplicated respiratory infections (acute pharyngitis, rhinosinusitis, acute bronchitis, COPD exacerbation). Patients were randomized to four treatment strategies: immediate prescription, no prescription, patient-led prescription (patients are given prescription on first consultation), and prescription collection strategy (patients collect the antibiotic at primary care office after the consultation). Both delayed strategy groups were told the same criteria on when to use or come back for antibiotics. The primary outcome of interest was duration and severity of symptoms as measured by daily self-reported questionnaires. Secondary outcomes included antibiotic use, satisfaction with health care, and absenteeism.

A total of 405 patients were recruited, and 398 included in analysis, which were primarily non-smokers without respiratory comorbidity. The duration of self-reported moderate symptoms in the immediate antibiotic group was statistically shorter and had a mean of 4.7 days (SD 4.0) as compared to 5.2 days (4.3), 6.0 days (5.5) and 6.5 days (5.2) in the collection, patient-led, and no prescription groups, respectively (p < 0.001). There was a similar pattern for severe symptoms (p = 0.002). The only individual symptom that had a significantly longer duration in the delayed or no prescription group was discomfort or general pain (p = 0.002). In the delayed strategies groups, only 23% and 32% of the collection and patient-led groups used antibiotics as compared to 92% of the immediate antibiotic group. Absenteeism was lower in both delayed groups (21.4% in prescription collection, 25.8% in patient-led) as compared to the higher rates in the immediate prescription group and no prescription group (33.3% and 39.8% respectively; p = 0.05).

Image: CC/Wiki

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: antibiotics
Previous Post

Turtle-associated salmonellosis reemerging as pediatric public health issue

Next Post

Selexipag may decrease mortality related to pulmonary arterial hypertension: The GRIPHON study

RelatedReports

Quick Take: Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG)
Hematology

Risk of bloodstream infections with indwelling peripheral catheters increase after 3 days

April 28, 2025
#VisualAbstract Seven Days of Antibiotic Treatment Non-inferior to 14 Days for Bloodstream Infections
StudyGraphics

#VisualAbstract Seven Days of Antibiotic Treatment Non-inferior to 14 Days for Bloodstream Infections

March 26, 2025
The 2 Minute Medicine Podcast Episode 15
2MM Podcast

The 2 Minute Medicine Podcast Episode 54

March 21, 2025
Oral amoxicillin as effective as injectable benzylpenicillin-gentamicin for infants with infection in which referral not possible [AFRINEST Trial]
Infectious Disease

Seven days of antibiotic treatment non-inferior to 14 days for bloodstream infections

March 18, 2025
Next Post
Selexipag may decrease mortality related to pulmonary arterial hypertension: The GRIPHON study

Selexipag may decrease mortality related to pulmonary arterial hypertension: The GRIPHON study

Azithromycin less effective compared to doxycycline for chlamydial infections

Azithromycin less effective compared to doxycycline for chlamydial infections

Antidepressant use associated with increased risk of subsequent mania

Antidepressant use associated with increased risk of subsequent mania

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Breast cancer survivors may have a lower risk of Alzheimer’s dementia
  • Evaluating scar outcomes in pediatric burn patients following skin grafting 
  • Novel inhibitory antibody, MAR001, lowers triglycerides and remnant cholesterol in humans
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.